HUNTSVILLE, Ala.–(BUSINESS WIRE)–August 13, 2020–
Madison Core Laboratories (“MCL”) introduced as we speak the launch of a company-wide initiative to turn out to be probably the most revolutionary diagnostic testing firm within the area and supply unsurpassed testing providers to raised serve purchasers.
This press launch options multimedia. View the total launch right here: https://www.businesswire.com/news/home/20200813005051/en/
The on-going COVID-19 pandemic has known as consideration to quite a few inefficiencies and issues plaguing the diagnostic trade. There are options available on the market that may handle many of those issues. Many testing laboratories don’t incorporate revolutionary options as a consequence of an absence of time, will or potential to adequately make the most of these new instruments. MCL is tackling testing for one of many hardest hit industries and sufferers within the nation: The Elderly inhabitants and Long-Term Care (LTC) amenities. We are the popular and, in some instances, the one cellular phlebotomy and laboratory supplier for a big section of the LTC market within the South East.
Madison Core Laboratories will take a proactive strategy to innovation and stand other than various testing laboratories. Our objective can be to determine inefficiencies and validate applicable options in-house with our extremely certified crew. We will proceed to emphasise innovation as a core firm precept.
A main instance of our dedication to innovation is the utilization of options to nucleic acid extraction. Such extractions, notably viral RNA extraction for COVID-19 testing, are at present a multi-step, time-consuming and costly course of. Madison Core Laboratories has recognized and validated Entopsis’ PCRopsisTMReagent RVD as an revolutionary resolution to this downside. Other impactful applied sciences provided by Entopsis and comparable corporations are at present being evaluated.
“I’m looking to transform MCL to an innovative industry leader. We are committed to offering clients unparalleled, accurate testing options in a timely fashion. To do so, we will utilize all tools at our disposal,” mentioned Carlo Crespo, M.D., CEO of Madison Core Laboratories.
“The Entopsis team’s mission is to develop impactful solutions to problems often considered intractable and then align ourselves with visionary industry leaders. MCL is such a partner,” mentioned Obdulio Piloto, Ph.D., CEO of Entopsis. “We have a suite of technologies that will offer laboratories meaningful alternatives to outdated processes in the diagnostic industry,” mentioned Francis Lim, Ph.D., Senior Scientist at Entopsis.
Madison Core Laboratories expects to finish the preliminary section of its innovation venture within the subsequent six months.
About Madison Core Laboratories:
Madison Core Laboratories is among the main impartial laboratories in Alabama. We present intensive laboratory providers utilizing state-of-the artwork testing gear to supply our purchasers with the newest improvements within the laboratory spectrum. Our purchasers embrace doctor places of work, long-term care amenities, assisted dwelling amenities, homebound sufferers, and industrial/company testing wants. MCL is the one impartial reference laboratory within the State of Alabama that provides cellular phlebotomy, molecular diagnostics, routine blood, urine, and toxicology testing all underneath one group.
Entopsis was based to pursue the straightforward concept that an unbiased strategy to diagnostics gives distinctive medical and scientific insights. The firm has two major platforms: (1) OpsisDxTM: nanotech platform powered by synthetic intelligence to concurrently diagnose a number of illnesses by urine and (2) PCRopsisTM: collection of novel analysis instruments that optimize analysis procedures. The firm is growing a set of revolutionary options to fight the COVID-19 pandemic that facilitate all points of testing on a world scale. Entopsis is backed by Peter Thiel’s Breakout Labs.
For Madison Core Laboratories